Global Access is focused on delivering sustainable, replicable, and scalable global strategies, policies, and solutions. Our work aims to support the Roche Pharma Vision and One Pharma Strategy and enables affiliates to drive patient access locally while maximizing the value for society, ecosystems, and business. We are operating in a highly networked and agile model with stable chapters and a variety of flexible squads and work product teams, operating across disease areas, functions, and geographies.

The therapeutic area of focus for this Position is Oncology. As one of the Access Strategy Leads (ASLs), you play a critical role in ensuring Roche and healthcare systems deliver rapid, broad, and sustainable patient access to innovative offerings. The ASL acts as a strategic thought partner and expert, collaborating with cross-functional teams to develop and implement effective access strategies to ensure our commercialization and development strategies fully reflect market conditions and access considerations. The ASL drives the strategic integration of access by ensuring that Global Access (GA) expertise, and access and policy considerations are effectively incorporated into development and commercialization strategies at all phases of the lifecycle, including asset strategies, disease area strategies, and commercialization strategies.

The Opportunity

• Serve as the Primary Point of Contact (PPOC) for the unified Access team, championing the Access/Payers perspective on the Commercial Leadership Teams and ensuring their needs and challenges are prioritized.

• Lead the development and implementation of holistic access strategies that are scalable, feasible, and balance patient access with sustainable pricing and reimbursement across markets.

• Assemble, synthesize, and distill access insights from research, affiliate feedback, and GA intelligence into a compelling Disease Area (DA) Access strategic brief to shape and refine the commercialization strategy.

• Ensure that the commercialization strategy seamlessly embeds access insights and deliverables by the unified Access team, and support the adoption of the access strategy in key markets by guiding local execution (providing Access Amplifier guidance and Objection handler support).

• Ensure alignment with Access partners so that registrational trials and other clinical and non-clinical evidence packages are supportive of the overall access strategy, including the Integrated Evidence Package (IEP).

• Co-create access materials and outputs that incorporate diverse stakeholder perspectives (such as HTA bodies, Payers, Policy Makers, Governments, Patients, Caregivers, and Society) to successfully support reimbursement submission and Access processes globally, and actively engage externally (e.g., Medical/Commercial Ad Board, Congresses).

• Develop access assessments to inform investment decisions, valuations, and asset strategies for pipeline products and business development opportunities, and empower and coach GA partners to deliver key insights for integrated access assessments, strategies, plans, and their implementation.

Who You Are

• A Bachelor's Degree (life sciences, health economics, marketing, or medical), MBA, or other relevant Graduate or Postgraduate Degrees is required.

• Significant pharmaceutical customer-facing experience, preferably in both global and country-level positions, or experience working within a cross-functional or integrated commercial team globally and locally.

• You must have 8+ years of access experience in the pharmaceutical or related industry, with multidisciplinary experience within and beyond Access being an advantage.

• The ability to work in a matrix organization, lead diverse teams to achieve common goals, and demonstrate strong knowledge of the drug development and commercialization process, as well as the current and future external environment.

• The capability to understand complex scientific issues, translate them into effective access and business strategies, operate in ambiguity, and deliver impactful messages/strategic recommendations to a broad range of stakeholders, with deep knowledge of the Access landscape (e.g., US, China, EU4, UK, Canada).